![Cho Hee Yun](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Cho Hee Yun formerly worked at Gilead Sciences, Inc., as Executive Director-Clinical Research, Ventyx Biosciences, Inc., as Vice President-Clinical Development, and Pliant Therapeutics, Inc., as Senior Vice President-Clinical Development from 2024 to 2025.
Dr. Yun received her undergraduate degree and doctorate degree from Seoul National University.
Former positions of Cho Hee Yun
| Companies | Position | End |
|---|---|---|
| PLIANT THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2025-04-30 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
| VENTYX BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Training of Cho Hee Yun
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
4
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Seoul National University
 Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pliant Therapeutics, Inc.
 Pliant Therapeutics, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company focuses on discovering and developing novel therapies for the treatment of fibrosis | Health Technology |
Ventyx Biosciences, Inc.
 Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
- Stock Market
- Insiders
- Cho Hee Yun
